Follow-up Study of Chondrogen® Delivered by Intra-Articular Injection Following Meniscectomy

• Status: Completed
• Trial end date: 2011-09-01
• Target enrollment: 0
• Participant gender: All

Summary

The objective of the present study is to establish the long-term safety of an intra-articular injection of human mesenchymal stem cells (hMSCs) (Chondrogen).

• Phase: Phase 1/Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Mesoblast International Sàrl

Criteria

Inclusion Criteria:

• Subject must have received an injection in Protocol No. 550

• Subject must have completed the 6-month and final 2-year visit in Protocol No. 550

• Subject must provide written informed consent for entry into the extension study

• Subject must provide authorization for use and disclosure of protected health information for entry into the extension study